The company manufactures kitchen appliances like chimneys, hobs, and gas stoves primarily as an original equipment manufacturer (OEM) for major Indian brands such as Havells, Hindware, and IFB.
The company lacks a durable moat as evidenced by an average net margin of -3.1% and ROCE of 0.9%, indicating no pricing power or cost advantage. While they claim a 'moat' through manufacturing complexity and BIS certification, the financial results show they are a price-taking commodity producer vulnerable to raw material fluctuations.
Capital has been deployed into aggressive capacity expansion in Hyderabad and Panchkula despite poor historical returns on equity. The reliance on debt and equity dilution to fund growth that has yet to yield positive net margins suggests a focus on scale over profitability.
The company's aggressive capacity expansion in Hyderabad and Panchkula proved to be a classic trap of 'profitless prosperity.' Despite rapid revenue growth, the business remained a price-taker, unable to pass on raw material spikes to customers while carrying a heavy debt load. The dilution of promoter equity and frequent turnover in the CFO office signaled internal instability that eventually led to a liquidity crunch when the anticipated margins from scale never materialized, leaving shareholders with a hollowed-out commodity producer.
RichFakir rates Inflame Appliances Ltd's business quality as poor — 24/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Inflame Appliances Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Inflame Appliances Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Inflame Appliances Ltd's fair value is about ₹53 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →